VA Uses DNA Analysis for Personalized Medication: Pharmacogenomics Program Explained

Pharmacogenomics Program Success

• 🚀 The VA's pharmacogenomics pilot program, launched in 2019, has been confirmed as a success.
• 🎯 This program aims to prevent medication side effects and reduce the use of ineffective medications by analyzing a patient's DNA.
• 🏥 Nearly every VA medical center is implementing or will implement pharmacogenomics testing by the end of 2026.

Provider Training and Integration

• 🎓 Over 1,000 VA providers have completed continuing education programs on pharmacogenomics.
• 🗣️ Academic detailing services have reached around 7,000 providers to promote the use of pharmacogenomics.
• 💻 The program is integrated into the VA's electronic health record as part of the clinical decision support system.

How DNA Guides Treatment

• 🧬 DNA analysis helps healthcare providers understand how a medication will behave in a patient's system and how their body will metabolize it.
• 🎯 This information allows for upfront selection of the most appropriate medication, removing the need for trial-and-error.
• 💊 The electronic health record flags alerts for approximately 100 evidence-based medications when pharmacogenomic testing results are available, guiding therapy selection.